Ejaculatory Disorders

Descriptive text is not available for this image Basics

Description

  • Group of dysfunctions involving altered time and control (premature ejaculation [PE], delayed ejaculation [DE]), presence (anejaculation [AE]), direction (retrograde ejaculation [RE]), volume (perceived ejaculate volume reduction [PEVR]), or force (decreased force of ejaculation [DFE]) of ejaculation
  • PE is defined as a persistent/recurrent pattern of ejaculation occurring during partnered sexual activity within 1 minute following vaginal penetration and before the individual wishes it + present for 6 months + causing significant distress for individual.
    • Natural biologic response is to ejaculate within 2 to 5 minutes after vaginal penetration.
    • Ejaculatory control is an acquired behavior that increases with experience.
    • Comorbidities common (diabetes, hypertension, sexual desire disorder, erectile dysfunction [ED])
  • DE: prolonged time to ejaculate (>30 minutes) despite desire, stimulation, and erection
  • Aspermia (lack of sperm in the ejaculate):
    • AE: lack of emission or contractions of bulbospongiosus muscle
    • RE: partial or complete ejaculation of semen into the bladder
    • Obstruction: ejaculatory duct obstruction or urethral obstruction
  • Also:
    • Painful ejaculation: genital or perineal pain during or after ejaculation
    • Ejaculatory anhedonia: normal ejaculation lacking orgasm or pleasure
    • Hematospermia: presence of blood in the ejaculate (often not a serious condition)

Epidemiology

Prevalence

  • PE is common; reported prevalence in American males is 5–20%.
  • DE is reported in 5–8% of men aged 18 to 59 years, but <3% have the problem for >6 months.
  • Predominant age: all sexually mature age groups

Etiology and Pathophysiology

Male sexual response:

  • Erection mediated by parasympathetic nervous system
  • Normal ejaculation consists of three phases:
    • Emission phase: Semen is deposited into urethra by contraction of prostate, seminal vesicles, vas deferens; under autonomic sympathetic control
    • Ejaculation phase: semen forcibly propelled out of urethra by rhythmic contractions of the bulbospongiosus and ischiocavernosus muscles; this is mediated by the somatic nervous system on the motor branches of the pudendal nerve. Bladder neck contracture by α-adrenergic receptors ensures anterograde ejaculation.
    • Orgasm: the pleasurable sensation associated with ejaculation (cerebral cortex); smooth muscle contraction of accessory sexual organs; release of pressure in posterior urethra
  • PE:
    • Hypersensitivity/hyperexcitability of glans penis
    • 5-hydroxytryptamine (5-HT) receptor sensitivity
    • Psychogenic (inexperience, anxiety/guilt, low frequency of sex, relationship problems)
    • Urologic (ED, prostatitis, urethritis)
    • Endocrine (hyperthyroid, obesity, diabetes)
    • Lack of physical or sexual activity
    • Withdrawal or detox from prescription or illicit drugs (e.g., opioids)
  • DE:
    • Rarely due to underlying painful disorder (e.g., prostatitis, seminal vesiculitis)
    • Often has a psychogenic component
    • Sometimes associated with low testosterone levels
    • Sexual performance anxiety and other psychosocial factors
    • Drugs or medications may impair ejaculation (e.g., MAOIs, SSRIs, α-blockers and β-blockers, thiazides, antipsychotics, tricyclic antidepressants, NSAIDs, opiates, alcohol, cannabis).
  • AE:
    • Never has ejaculate: congenital structural disorder (müllerian duct cyst, Wolffian abnormality)
    • Acquired causes: surgery (radical prostatectomy, retroperitoneal lymph node dissection), spinal cord injury or other sympathetic nerve injury (especially T10–T12 level), diabetes mellitus (DM) with neuropathy, and medications (α-blockers and β-blockers, benzodiazepines, SSRIs, MAOIs, TCAs, antipsychotics, aminocaproic acid)
  • RE:
    • Transurethral resection of the prostate (25%) or other prostate resection procedures
    • Surgery on the neck of the bladder
    • Extensive pelvic surgery
    • Retroperitoneal LN dissection for testicular cancer (also may produce failure of emission)
    • Neurologic disorders (multiple sclerosis [MS], DM)
    • Medications (tamsulosin, other α-blockers, SSRIs, antipsychotics)
    • Urethral stricture (may be posttraumatic)
  • Painful ejaculation:
    • Infection or inflammation (orchitis, epididymitis, prostatitis, urethritis)
    • Ejaculatory duct obstruction
    • Seminal vesicle calculi
    • Obstruction of the vas deferens
    • Psychological/functional
  • Hematospermia (often unable to find cause):
    • Usually not a serious condition
    • Inflammation/infection
    • Calculi: bladder, seminal vesicle, prostate, urethra
    • Trauma to genital area (cycling, constipation, masturbation)
    • Obstruction
    • Cyst
    • Tumor (1–3% prostate cancers present with hematospermia)
    • Arteriovenous malformations
    • Iatrogenic
    • Hypertension

Risk Factors

ED: pudendal neuralgia, substance use, psychotropic medications, psychological distress, or relationship issue

General Prevention

Screen for sexually transmitted infections (STIs).

Commonly Associated Conditions

  • Neurologic disorders (e.g., multiple sclerosis)
  • Diabetes
  • Prostatitis
  • Ejaculatory duct obstruction
  • Urethral stricture
  • Psychological disorders
  • Endocrinopathies
  • Relationship/interpersonal difficulties

There's more to see -- the rest of this topic is available only to subscribers.